Cannabis sales and use are high in Michigan — but federal law means research lags behind.

Have you been to a licensed cannabis dispensary recently?

mine The team and me We often visit cannabis users within the Greater Lansing area to ask them to take part in our studies. As we enter, we’re met with a formidable array of products: high potency vape cartridges, gourmet gummies, premium marijuana flowers and more.

This big selection of decisions is typical of a state like Michigan. Per capita sales now rank among the highest in the country.. I confess that I have a look at these shelves with some skilled dismay. As Researchers at Michigan State University Having spent nearly 20 years studying cannabis use and human health, I face severe restrictions under federal law that mean I cannot study the products that lots of my neighbors are buying.

Under federal law, cannabis a Schedule I drugs. According to the designation, cannabis has a “high potential for abuse” and is “not currently accepted for medical use,” though Millions of Americans use it every day.. Other Schedule I drugs include heroin and LSD.

In my view, the proposal to reclassify cannabis from Schedule I to Schedule III represents a very important, albeit incomplete, step forward. The change was introduced throughout the Biden administration and backed by an executive order signed by President Donald Trump in late 2025, but it surely appears Stuck in a regulatory quagmire.

For researchers like myself, whose work is to know how this widely available substance affects the health of Michiganders, this alteration opens some doors while leaving other essential hurdles in place.

1 in 6 pregnant Michiganders use cannabis.

Michigan’s strong legal market has seen a surge recently. Dispensary closures due to excessive pricing and falling prices. However, access continues to be wide.

Cannabis is widely utilized in Michigan’s diverse communities. Upper Peninsula from Detroit. The data my colleagues and I actually have collected confirms that use isn’t only high overall, but particularly prevalent in certain populations, including Older adults And Pregnant women.

As more women of reproductive age Use cannabisit becomes more essential to research how prenatal exposures affect the health of moms and kids. This will allow researchers to supply clear information to families across Michigan who’re making decisions in a landscape where cannabis is legally accessible and socially normalized.

However, federal law limits researchers to cannabis samples. National Institute on Drug Abusewhich frequently bears little resemblance to the products Michiganders actually use. Institute provides low-potency, quality products, while the business market is flooded with high-potency concentrates, edibles, and vapes. This limits the real-world applicability of our findings.

Heart disease, diabetes, cancer, nausea

Much of my research has focused on using cannabis by these people. Chronic disease. Michigan was legalized. Recreational Use of Cannabis in 2018 By popular referendum, and use is Very common between Middle-aged and older adults.

At the identical time, Michigan grapples with a high burden of chronic diseases, e.g Heart disease, diabetes and cancer. gave The risk of these conditions increases with age.. In southeast Michigan, the burden is much more acute. Oh Forbes analysis Detroit was ranked because the nation’s least healthy city, with the very best rates of diabetes, hypertension and obesity. These conditions disproportionately affect black residents, who make up about 80 percent of town’s population.

An essential a part of My research Attempts to elucidate the consequences of cannabis use on cardiovascular health. This work is particularly essential in Michigan, where Heart disease rates are consistently high. Moving cannabis to Schedule III would facilitate larger, more rigorous longitudinal studies, reminiscent of my team’s Cannabis Legalization, or CALM, cohort in Michigan. For example, if a Michigander has hypertension and uses a high-THC vape product, we would like to understand how that affects their heart health in comparison with using other kinds of drugs. We cannot design a rigorous study to reply this query because we’re restricted from using specific products purchased by consumers at dispensaries.

My research team and others are also investigating. Cannabinoid hyperemesis syndromea condition characterised by cycles of severe nausea, vomiting and abdominal pain that may occur with chronic cannabis use. As regular cannabis use increases amongst Michiganders, understanding who’s in danger and easy methods to treat this debilitating syndrome has develop into a very important medical priority.

Obstacles will remain.

Even when the rescheduling occurs, significant obstacles to cannabis research will remain.

Schedule III was designed for prescription pharmaceuticals, reminiscent of steroids and testosterone, not substances available at a store down the road. Moving cannabis to Schedule III doesn’t resolve the elemental conflict between federal drug policy and real-world consumption in Michigan and across the United States.

The mismatch between federal law and the patchwork of state cannabis policies would also mean that federally funded, multi-site studies are limited to states where cannabis is fully legal, reducing the geographic scope and variety of our research. It also doesn’t eliminate the unique administrative burdens that apply only to cannabis research. These burdens add years and increase the fee of studies which can be urgently needed. For example, researchers often face long delays in federal review before studies can begin.

Researchers can conduct more useful studies using products that buyers buy of their neighborhoods. This can be possible through Removing lengthy federal review requirementsA change that will require congressional motion.

gave Medical Marijuana and Cannabidiol Research Expansion Act of 2022 It was a step in that direction. It goals to streamline the appliance process for researchers and increase the availability of research-grade cannabis. However, it didn’t eliminate the underlying Schedule I classification or redundant federal reviews that proceed to delay research.

For people in Michigan, where cannabis is straightforward to purchase and chronic disease is common, these policy restrictions leave families without the science they should make informed decisions.